EICHOR
● Completed
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohn Disease · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy of ustekinumab dosing in inducing clinical remission (Global) and in maintaining clinical remission (US); to evaluate the safety profile and ustekinumab exposure (pharmacokinetics \[PK\]) in pediatric participants with moderately to severely active Crohn's disease.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (53)
| Nemours DuPont Hospital for Children | Wilmington, Delaware, United States | — |
| Children's Center for Digestive Health Care | Atlanta, Georgia, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| Morristown Memorial Hospital | Morristown, New Jersey, United States | — |
| Levine Childrens at Atrium Health | Charlotte, North Carolina, United States | — |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | — |
| Penn State Hershey Children's Hospital | Hershey, Pennsylvania, United States | — |
| Cook Childrens Medical Center | Fort Worth, Texas, United States | — |
| Pediatric Specialists Of Virginia | Fairfax, Virginia, United States | — |
| Universitair Kinderziekenhuis Koningin Fabiola | Brussels, Belgium | — |
| Cliniques Universitaires Saint Luc | Brussels, Belgium | — |
| UZ Gent | Ghent, Belgium | — |
+ 41 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04673357